Finance

Lists
524348:BOM
Aarti Drugs Ltd
₹403,00
-1,80%
(-7,40) 1D
14 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524348...
Open
₹408,25
High
₹409,20
Low
₹399,55
Mkt. cap
36,76 mjd
Avg. vol.
11,09 k
Volume
6,13 k
Dividend
0,50%
Quarterly dividend
₹0,50
Ex-dividend date
09 Feb. 2026
P/E ratio
19,25
52-wk high
₹533,60
52-wk low
₹318,60
EPS
₹20,94
Shares outstanding
23,58 m
No. of employees
1 k
Open
₹408,25
High
₹409,20
Low
₹399,55
Mkt. cap
36,76 mjd
Avg. vol.
11,09 k
Volume
6,13 k
Dividend
0,50%
Quarterly dividend
₹0,50
Ex-dividend date
09 Feb. 2026
P/E ratio
19,25
52-wk high
₹533,60
52-wk low
₹318,60
EPS
₹20,94
Shares outstanding
23,58 m
No. of employees
1 k
News stories
From web sources and news partners
About Aarti Drugs Ltd
CEOPrakash M. Patil
Employees1,36 k
Founded1984
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
6,53 mjd
6,02 mjd
7,20 mjd
7,03 mjd
Cost of goods sold
4,08 mjd
3,87 mjd
4,75 mjd
4,28 mjd
Cost of revenue
4,08 mjd
3,87 mjd
4,75 mjd
4,28 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
330,70 m
331,60 m
353,24 m
365,10 m
Operating expense
1,76 mjd
1,77 mjd
1,69 mjd
1,95 mjd
Total operating expenses
5,85 mjd
5,63 mjd
6,44 mjd
6,22 mjd
Operating income
681,20 m
383,20 m
761,27 m
805,50 m
Other non operating income
-91,00 k
16,00 k
12,15 m
-
EBT including unusual items
604,11 m
290,32 m
703,57 m
692,40 m
EBT excluding unusual items
604,11 m
290,32 m
703,57 m
713,30 m
Income tax expense
152,50 m
-115,20 m
150,94 m
191,10 m
Effective tax rate
25,24%
-39,68%
21,45%
27,60%
Other operating expenses
1,27 mjd
1,26 mjd
1,16 mjd
1,40 mjd
Net income
452,80 m
405,40 m
551,97 m
501,70 m
Net profit margin
6,94%
6,74%
7,66%
7,14%
Earnings per share
4,95
-
-
5,66
Interest and investment income
-
-
11,69 m
-
Interest expense
-77,00 m
-92,90 m
-81,55 m
-92,20 m
Net interest expenses
-77,00 m
-92,90 m
-69,85 m
-92,20 m
Depreciation and amortization charges
162,60 m
179,50 m
180,41 m
184,60 m
EBITDA
836,10 m
515,81 m
916,49 m
972,92 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme